Assessment and Treatment of Sexual Dysfunction

Female sexual interest/arousal disorder is classified under orgasm disorders in the DSM-5.

The ICD-10 includes lack or loss of sexual desire as a type of sexual dysfunction not caused by organic disorders.

Genitopelvic pain/penetration disorder is classified under sexual dysfunction in the DSM-5.

Delayed ejaculation is classified under sexual desire disorders in both DSM-5 and ICD-10.

Excessive sexual drive is included in the category of non-organic dysparenia in the ICD-10.

Prostate cancer is commonly associated with sexual dysfunction.

Calcium channel blockers are known to enhance sexual function.

Mastectomy is a surgical procedure that has no impact on sexual function.

SSRIs are classified as drugs that may impair sexual function.

Asthma is a cardiovascular condition that affects sexual dysfunction.

The assessment of sexual dysfunction should ideally involve both the patient and their sexual partner.

Hypotension is a medical condition commonly associated with sexual dysfunction.

Renal failure is included in the 'other' category of conditions associated with sexual dysfunction.

Psychological interventions have been proven ineffective for treating sexual dysfunction.

Sex therapy was developed by Masters and Johnson in 1970.

PDE-5 inhibitors are primarily used for treating female sexual dysfunction.

A physical examination for sexual dysfunction often includes assessment of hair distribution.

In sex therapy, partners are typically treated individually.

Sensate Focus involves a series of structured touching techniques to reduce performance anxiety.

Sexual drive is a secondary consideration in assessing sexual dysfunction.

The first step in treating sexual dysfunction involves providing assurance and addressing underlying causes.

Gynaecomastia is assessed during the genital examination for male sexual dysfunction.

Substance misuse is not considered a potential cause of sexual dysfunction.

The prevalence of sexual dysfunction among premenopausal women is estimated to be 50%.

Around 40% of women reported a lack of sexual interest lasting for 6 months.

Male erectile dysfunction was reported by 9% of men for a duration longer than 6 months.

Psychological factors do not influence sexual dysfunction in individuals.

Erectile dysfunction can serve as an early marker for cardiovascular disease.

The majority of sexual problems reported in the UK sample lasted for more than 6 months.

Intoxication from alcohol can impair sexual performance.

The inability to reach orgasm was reported by 14% of women for more than 6 months.

The reported response rate for the sexual dysfunction survey in the UK was 70%.

Male premature orgasm was reported by 12% of men lasting for 1 month.

PDE-5 inhibitors are effective in approximately 70% of erectile dysfunction cases.

Hypoactive sexual desire disorder only affects men.

Sexual skills training is categorized under psychological methods for treating sexual dysfunction.

Female sexual arousal disorder is now treated separately from hypoactive sexual desire disorder in DSM-5.

The inability to sustain an erection for satisfactory coitus is known as male erectile disorder.

Testosterone is commonly used to treat women with hypoactive sexual desire disorder.

Systematic desensitization is a method used in sex therapy.

Loss of sexual desire in men is categorically classified as a primary male erectile disorder.

Physical examinations and blood tests are unnecessary when assessing erectile dysfunction.

Vacuum devices and dilators are considered drug treatments for sexual dysfunction.

In the past, sexual dysfunction and preference disorders were primarily seen as physical medical issues.

Homosexuality was classified as a psychiatric disorder until the 1980s.

In contemporary psychiatry, sex therapy is primarily conducted within specialized clinics.

Sexual dysfunction in women refers primarily to repeated impairment of sexual performance and interest.

The DSM-5 states that disorders of sexual function must last at least three months for diagnosis.

Paraphilias are considered uncommon and can have forensic implications.

Gender dysphoria is defined as a perfect alignment between one's identity and anatomical sex.

A brief sexual history is no longer considered important in psychiatric assessments.

The 2013 study showed that the vast majority of men identified as heterosexual.

There is a universally agreed definition of sexual dysfunction in psychiatry.

PDE-5 inhibitors have completely replaced treatments such as intra-cavernosal injections for erectile dysfunction.

Many women who do not reach orgasm during intercourse report significant distress about this issue.

Male Orgasmic Disorder is solely caused by psychological inhibition.

Premature ejaculation is more frequently observed in younger women than in younger men.

Pain during intercourse, known as dyspareunia, can result from various factors, including inadequate lubrication.

Vaginismus can occur even when a woman attempts to introduce her own finger into the vagina.

The use of SSRIs is always necessary for the treatment of premature ejaculation.

Abnormalities of sexual preference, also known as paraphilias, have always been viewed positively throughout history.

The treatment of dyspareunia often requires an initial prohibition on attempts at intercourse.

The accepted view of what is considered 'normal' sexual preference is consistent across all societies and eras.

The prevalence of paedophilic disorder is estimated to range from 1% to 7% in the male population.

Voyeruistic behaviour can sometimes be accompanied by masturbation.

Exhibitionistic behaviour is reported to occur at rates as high as 5% to 10% in the general population.

Frotteuristic activity most commonly occurs among individuals over the age of 30.

Sexual sadism is classified as one of the most common forms of sexual activity.

Fetishistic disorder is classified under abnormalities of the act of sexual preference.

The aetiology of paraphilias is well understood with strong supporting evidence.

Alfred Binet proposed that fetishism arises from the chance co-occurrence of sexual excitement with the object that later becomes the fetish object.

Sexual masochism disorder is categorized under abnormalities of the object of sexual interest.

Paraphilias that start in middle age may be secondary to dementia or other organic disorders.

Psychophysiological assessments are routinely used in the assessment of abnormalities of sexual preference.

Obtaining consent from a regular sexual partner is not important during the assessment of sexual preferences.

The relationship of the interview to possible legal proceedings should be explained to the patient.

Castration anxiety that is unresolved in childhood may lead to the development of fetishism.

Patients often approach doctors about sexual behavior due to overwhelming desire for change.

The estimated prevalence of fetishistic disorder in men ranges from 1-18%.

Transvestic disorder is equally prevalent in men and women.

Paedophilia is characterized by sexual activity with post-pubertal children.

All types of treatment for paraphilias are equally supported by high-quality evidence.

The preferred means of sexual excitement in fetishistic disorder typically involves direct sexual associations.

Individuals with transvestic disorder frequently report being sexually aroused by cross-dressing.

Psychotherapy as a treatment strategy for paraphilias includes counseling, education, and social skills training.

Clinical implications of paedophilia are generally considered benign.

Fetishistic disorder is considered abnormal when it does not precede usual patterns of sexual intercourse.

The onset of transvestic disorder typically occurs at puberty.